Congress trades

Baxter International Inc. (BAX)

NYSE · Healthcare · 360 insider transactions · 124 congress trades · last filed 2 months agoS&P 500

20
Congress disclosures shown
24d
Median delay on the congress disclosures
of the 45 day limit
11 buys·9 sells
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades BAX.

Free on iOS and Android.

About Baxter International Inc.

from the company's filings and listing, as of Oct 25, 2026
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Chief executive
Andrew Hider
Employees
37,500
Listed since
Oct 27, 1981
Market value
$13.1B
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-$2.06
Dividend yield
0.16%

www.baxter.com

Earnings

6 reported quarters · next on Oct 29, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 30, 2026$0.56$0.37$3.0B$2.8BEPS beatRevenue beat
Q1 FY2026reported Apr 30, 2026$0.36$0.31$2.7B$2.6BEPS beatRevenue beat
Q4 FY2025reported Feb 12, 2026$0.44$0.53$3.0B$2.8BEPS missRevenue beat
Q3 FY2025reported Oct 30, 2025$0.69$0.60$2.8B$2.8BEPS beatRevenue in line
Q2 FY2025reported Jul 31, 2025$0.59$0.60$2.8B$2.9BEPS missRevenue miss
Q1 FY2025reported May 1, 2025$0.55$0.48$2.6B$2.6BEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2025 · proxy filed Mar 23, 2026
ExecutiveSalaryStock awardsOtherTotal
Reazur RasulExecutive Vice President and Group President, Healthcare Systems & Technologies$800K$3.0M$1.5M$5.2M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 3 executives who have since left the company are named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$1.7B81,842,105+3.1%15.83%
Pzena Investment Management LLC$1.4B65,295,393+1.2%12.63%
Dodge & Cox$1.2B58,386,345+2.0%11.29%
FMR LLC$1.1B53,913,831+16.5%10.43%
Vanguard Capital Management LLC$719.6M33,754,280+0.7%6.53%
Vanguard Portfolio Management LLC$512.9M24,057,190+0.3%4.65%
State Street Corp$439.4M20,600,468+3.1%4.00%
Greenhaven Associates Inc$304.6M14,285,228-0.2%2.76%
Geode Capital Management, LLC$300.6M14,123,689+2.6%2.73%
Invesco Ltd.$263.6M12,361,881-5.8%2.39%
UBS Group AG$203.2M9,529,309+120.6%1.84%
First Pacific Advisors, LP$162.4M7,618,145+13.7%1.47%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Know when the next BAX filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Other Form 4 activity (20)
InsiderEventSharesDate
Julie FosterPresident, Front Line CareTax withholding2,098Sep 2, 2026
Andrew P. HiderPresident and CEOTax withholding54,276Sep 2, 2026
James TeaffPresident, CCSTax withholding750Sep 1, 2026
William A. Ampofo IIDirectorStock award12,836May 5, 2026
Jeffrey A. CraigDirectorStock award12,836May 5, 2026
Michael R. McDonnellDirectorStock award12,836May 5, 2026
David Brent ShaferDirectorStock award12,836May 5, 2026
Patricia MorrisonDirectorStock award12,836May 5, 2026
Nancy M. SchlichtingDirectorStock award12,836May 5, 2026
Amy McBride WendellDirectorStock award12,836May 5, 2026
David S. WilkesDirectorStock award12,836May 5, 2026
James TeaffPresident, CCSOther Form 4 entry (see filing)55,119Apr 1, 2026
Steven P. WallacePresident, Adv. SurgeryOther Form 4 entry (see filing)67,972Apr 1, 2026
Julie FosterPresident, Front Line CareOther Form 4 entry (see filing)25,862Apr 1, 2026
Joel T. GradeEVP and CFOTax withholding8,153Mar 6, 2026
Reazur RasulEVP, Group Pres, HealthcareTax withholding12,674Mar 6, 2026
David S. RosenbloomEVP and General CounselTax withholding6,620Mar 6, 2026
Maria Cecilia SorianoGroup Pres., ITT & Pharma.Tax withholding2,848Mar 6, 2026
Anita A. ZielinskiSVP, CAO and ControllerTax withholding1,932Mar 6, 2026
Anita A. ZielinskiSVP, CAO and ControllerStock award30,864Feb 27, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Congress trades in BAX

20 disclosures of 124 on record · median 24d of the 45 allowed

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockPurchase$1,001 - $15,000+47.0% since the tradeEstimated entry price $17.21, close on Fri May 1Current price $25.30, close on Fri Oct 23May 1, 2026Jun 9, 202639d
Ro KhannaStockPurchase$1,001 - $15,000+46.2% since the tradeEstimated entry price $17.30, close on Fri May 15Current price $25.30, close on Fri Oct 23May 15, 2026Jun 9, 202625d
Ro KhannaStockPurchase$1,001 - $15,000+30.9% since the tradeEstimated entry price $19.33, close on Wed May 27Current price $25.30, close on Fri Oct 23May 27, 2026Jun 9, 202613d
Ro KhannaStockSale$1,001 - $15,000+39.3% since the saleEstimated exit price $18.16, close on Fri Apr 24Current price $25.30, close on Fri Oct 23Apr 24, 2026May 11, 202617d
Ro KhannaStockSale$1,001 - $15,000+43.5% since the saleEstimated exit price $17.63, close on Mon Apr 13Current price $25.30, close on Fri Oct 23Apr 13, 2026May 11, 202628d
Ro KhannaStockSale$1,001 - $15,000+60.1% since the saleEstimated exit price $15.80, close on Mon Mar 30Current price $25.30, close on Fri Oct 23Mar 30, 2026Apr 7, 20268d
Michael T. McCaulStockPurchase$100,001 - $250,000+22.0% since the tradeEstimated entry price $20.74, close on Tue Feb 17Current price $25.30, close on Fri Oct 23Feb 17, 2026Mar 10, 202621d
Ro KhannaStockPurchase$1,001 - $15,000+22.0% since the tradeEstimated entry price $20.74, close on Tue Feb 17Current price $25.30, close on Fri Oct 23Feb 17, 2026Mar 9, 202620d
Michael T. McCaulStockPurchase$50,001 - $100,000+28.8% since the tradeEstimated entry price $19.65, close on Tue Jan 13Current price $25.30, close on Fri Oct 23Jan 13, 2026Feb 11, 202629d
Ro KhannaStockPurchase$1,001 - $15,000+28.2% since the tradeEstimated entry price $19.73, close on Thu Jan 29Current price $25.30, close on Fri Oct 23Jan 29, 2026Feb 6, 20268d
Ro KhannaStockSale$1,001 - $15,000+42.5% since the saleEstimated exit price $17.75, close on Mon Nov 10, 2025Current price $25.30, close on Fri Oct 23Nov 10, 2025Dec 8, 202528d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000+32.0% since the tradeEstimated entry price $19.16, close on Thu Oct 30, 2025Current price $25.30, close on Fri Oct 23Oct 30, 2025Nov 21, 202522d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+32.0% since the saleEstimated exit price $19.16, close on Thu Oct 30, 2025Current price $25.30, close on Fri Oct 23Oct 30, 2025Nov 21, 202522d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+37.0% since the saleEstimated exit price $18.47, close on Fri Oct 31, 2025Current price $25.30, close on Fri Oct 23Oct 31, 2025Nov 21, 202521d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000+16.5% since the tradeEstimated entry price $21.71, close on Thu Sep 25, 2025Current price $25.30, close on Fri Oct 23Sep 25, 2025Oct 22, 202527d
Ro KhannaStockSale$1,001 - $15,000+7.5% since the saleEstimated exit price $23.54, close on Wed Sep 3, 2025Current price $25.30, close on Fri Oct 23Sep 3, 2025Oct 3, 202530d
Ro KhannaStockSale$1,001 - $15,000+3.6% since the saleEstimated exit price $24.42, close on Fri Sep 5, 2025Current price $25.30, close on Fri Oct 23Sep 5, 2025Oct 3, 202528d
Ro KhannaStockPurchase$1,001 - $15,000+13.0% since the tradeEstimated entry price $22.38, close on Mon Sep 29, 2025Current price $25.30, close on Fri Oct 23Sep 29, 2025Oct 3, 20254d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+12.7% since the saleEstimated exit price $22.44, close on Mon Aug 4, 2025Current price $25.30, close on Fri Oct 23Aug 4, 2025Sep 12, 202539d
Ro KhannaStockPurchase$1,001 - $15,000+12.7% since the tradeEstimated entry price $22.44, close on Mon Aug 4, 2025Current price $25.30, close on Fri Oct 23Aug 4, 2025Sep 9, 202536d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

Every Congress trade in BAX, filterable by party, chamber, type and account.

Members of Congress reporting a position

3 members · estimate, as of Oct 24, 2026

3 members report a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Lucy McBathDemocrat · House$1,001 - $15,0000.2%
Robert BresnahanRepublican · House$1,001 - $15,0000.1%
Debbie Wasserman SchultzDemocrat · House$1,001 - $15,00022.6%

Estimate, as of Oct 24, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Which members of Congress have traded BAX?

Ro Khanna, Michael T. McCaul and Lisa C. McClain disclosed BAX transactions in the filings shown here.

Which members of Congress hold BAX?

3 members of Congress report a position in BAX in the estimate we hold as of Oct 24, 2026. The estimated positions belong to Lucy McBath, Robert Bresnahan and Debbie Wasserman Schultz. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is BAX in the S&P 500 or the Nasdaq 100?

Baxter International Inc. is a current member of the S&P 500, per the membership list we hold as of Oct 27, 2026. Current members of either index get a page here whatever their filing history.

How quickly are BAX trades disclosed?

Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 27, 2026.

Related companies

traded by the same members

See every company we track